Skip to content
NewsBlazeAU – Lifestyle
Author:
RACURA ONCOLOGY LTD
Racura Oncology’s RC220 Matches RC110 Drug Exposure in Nonclinical Bridging Study, Linking RC220 to Prior Clinical Experience in AML
November 17, 2026